Search

Your search keyword '"Fokkens, W J"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Fokkens, W J" Remove constraint Author: "Fokkens, W J" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
37 results on '"Fokkens, W J"'

Search Results

1. Quality of Life in CSF Leak

3. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

4. EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care

6. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study

7. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

8. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023

9. Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

10. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

11. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

12. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

13. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023

14. The ARIA-MeDALL hypothesis

15. Additional file 1 of Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes

17. The EUFOREA pocket guide for chronic rhinosinusitis.

18. Development and validation of combined symptom-medication scores for allergic rhinitis*

19. Recent advances in chronic rhinosinusitis: pathophysiology, treatments, and outcome measures.

20. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control.

21. The impact of mepolizumab on sleep impairment in CRSwNP: post hoc analyses of SYNAPSE and MUSCA.

22. Outcome measures for chronic rhinosinusitis with nasal polyps.

23. Steroid responsiveness predicts olfactory function recovery in dupilumab treated CRSwNP.

25. Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polyps.

26. Mepolizumab improves sense of smell in severe chronic rhinosinusitis with nasal polyps: SYNAPSE.

27. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.

28. Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps.

30. Evaluating treatment response to mepolizumab in patients with severe CRSwNP.

32. Measuring control of disease in Chronic Rhinosinusitis; assessing the correlation between SinoNasal Outcome Test-22 and Visual Analogue Scale item scores.

33. Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.

36. Endoscopic grading systems for nasal polyps: are we comparing apples to oranges?

37. Rhinology in review: from COVID-19 to biologicals.

Catalog

Books, media, physical & digital resources